A mutation in the variant’s spike protein could be to blame for its increased spread and some immune-evasive properties. However, the CDC has noted that even so, “there is no evidence that JN.1 presents an increased risk to public health relative to other currently circulating variants.”
Less than two weeks ago, around Dec. 13, JN.1 accounted for only 21% of cases. Now that has more than doubled.
Trailing JN.1, is another variant, HV.1, making up 22.1% of cases nationally.
JN.1’s dominance around the holidays was predicted by experts, one of whom told The Wall Street Journal Dec. 6 that the variant’s spike during Christmas likely “means that it would really jump-start a new wave around New Year’s,” Katelyn Jetelina, PhD, a scientific adviser to the CDC told the outlet.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
